Airway Microbiota as a Modulator of Lung Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Apr 2020
Historique:
received: 12 04 2020
revised: 24 04 2020
accepted: 24 04 2020
entrez: 3 5 2020
pubmed: 3 5 2020
medline: 2 2 2021
Statut: epublish

Résumé

Recent research on cancer-associated microbial communities has elucidated the interplay between bacteria, immune cells, and tumor cells; the bacterial pathways involved in the induction of carcinogenesis; and their clinical significance. Although accumulating evidence shows that a dysbiotic condition is associated with lung carcinogenesis, the underlying mechanisms remain unclear. Microorganisms possibly trigger tumor initiation and progression, presumably via the production of bacterial toxins and other pro-inflammatory factors. The purpose of this review is to discuss the basic role of the airway microbiome in carcinogenesis and the underlying molecular mechanisms, with the aim of developing anticancer strategies involving the airway microbiota. In addition, the mechanisms via which the microbiome acts as a modulator of immunotherapies in lung cancer are summarized.

Identifiants

pubmed: 32357415
pii: ijms21093044
doi: 10.3390/ijms21093044
pmc: PMC7246469
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):731-740
pubmed: 30733306
Cell Host Microbe. 2015 May 13;17(5):704-15
pubmed: 25865368
Lung Cancer. 2016 Dec;102:89-95
pubmed: 27987594
J Adv Res. 2019 Mar 23;19:105-112
pubmed: 31341676
PLoS One. 2012;7(10):e47305
pubmed: 23071781
Lung Cancer. 2019 Oct;136:129-135
pubmed: 31494531
PLoS One. 2010 Jan 05;5(1):e8578
pubmed: 20052417
Am J Respir Crit Care Med. 2009 Jan 1;179(1):11-8
pubmed: 18948425
J Clin Med. 2020 Feb 20;9(2):
pubmed: 32093372
Br J Nutr. 2014 Feb;111(3):387-402
pubmed: 23931069
Int J Mol Sci. 2019 Mar 22;20(6):
pubmed: 30909462
Mediators Inflamm. 2019 Nov 11;2019:7652014
pubmed: 31827379
PLoS One. 2011 Feb 22;6(2):e16384
pubmed: 21364979
Thorax. 2012 Dec;67(12):1075-80
pubmed: 22863758
Int J Inflam. 2012;2012:686739
pubmed: 22762009
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Int J Mol Sci. 2020 Jan 17;21(2):
pubmed: 31963413
Cell Host Microbe. 2013 Aug 14;14(2):195-206
pubmed: 23954158
Vaccines (Basel). 2019 Aug 26;7(3):
pubmed: 31455032
EBioMedicine. 2019 Oct;48:642-647
pubmed: 31597596
Nat Rev Microbiol. 2011 Apr;9(4):279-90
pubmed: 21407244
Am J Respir Crit Care Med. 2017 Jun 15;195(12):1640-1650
pubmed: 28085486
J Microbiol Methods. 2010 Jul;82(1):98-101
pubmed: 20382190
J Allergy Clin Immunol. 2013 Feb;131(2):346-52.e1-3
pubmed: 23265859
N Engl J Med. 2007 Oct 11;357(15):1487-95
pubmed: 17928596
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1308-15
pubmed: 18544646
Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1101-11
pubmed: 24449346
Chest. 2002 Jun;121(6):1782-8
pubmed: 12065339
Int J Cancer. 2018 Feb 15;142(4):769-778
pubmed: 29023689
Genome Res. 2012 Feb;22(2):299-306
pubmed: 22009989
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1498-505
pubmed: 20501758
Nat Chem Biol. 2011 Dec 15;8(1):36-45
pubmed: 22173358
Front Microbiol. 2018 Aug 06;9:1757
pubmed: 30127774
Exp Mol Med. 2017 Apr 14;49(4):e316
pubmed: 28408748
Appl Environ Microbiol. 1999 Nov;65(11):4799-807
pubmed: 10543789
J Clin Microbiol. 2014 Dec;52(12):4217-23
pubmed: 25253795
J Clin Invest. 2014 Oct;124(10):4166-72
pubmed: 25105360
Int J Mol Sci. 2020 Feb 23;21(4):
pubmed: 32102237
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11971-5
pubmed: 20566857
Eur Respir Rev. 2013 Sep 1;22(129):376-81
pubmed: 23997064
Respir Res. 2017 Feb 1;18(1):29
pubmed: 28143484
Radiother Oncol. 2013 Jun;107(3):389-91
pubmed: 23684589
Cancer Lett. 2018 Feb 28;415:40-48
pubmed: 29197615
Environ Mol Mutagen. 2014 Oct;55(8):643-51
pubmed: 24895247
Am J Cancer Res. 2019 Sep 01;9(9):2047-2063
pubmed: 31598405
J Thorac Dis. 2019 Jan;11(1):280-291
pubmed: 30863606
Eur Respir J. 2012 Feb;39(2):419-28
pubmed: 21778164
Nat Commun. 2019 Nov 1;10(1):5001
pubmed: 31676759
Am J Epidemiol. 2011 Feb 1;173(3):310-8
pubmed: 21190986
J Clin Med. 2019 Nov 01;8(11):
pubmed: 31683962
Cancer Res. 2014 Aug 1;74(15):4030-41
pubmed: 24947042
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):672-8
pubmed: 21335509
Am J Respir Crit Care Med. 2014 Oct 15;190(8):906-13
pubmed: 25184687
Science. 2015 Sep 4;349(6252):1106-10
pubmed: 26339029
PLoS Comput Biol. 2012;8(12):e1002808
pubmed: 23300406
mBio. 2012 Aug 21;3(4):
pubmed: 22911969
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1188-1198
pubmed: 29864375
PLoS One. 2017 May 25;12(5):e0177062
pubmed: 28542458
Am J Respir Crit Care Med. 2012 May 15;185(10):1073-80
pubmed: 22427533
N Engl J Med. 2013 Jan 31;368(5):407-15
pubmed: 23323867
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
Nature. 2007 Oct 18;449(7164):804-10
pubmed: 17943116
Nat Rev Immunol. 2001 Oct;1(1):69-75
pubmed: 11905816
Cancer Cell. 2015 Dec 14;28(6):687-689
pubmed: 26678336
Int J Mol Sci. 2019 Mar 18;20(6):
pubmed: 30889843
Genome Biol. 2018 Aug 24;19(1):123
pubmed: 30143034
Sci Rep. 2019 Sep 6;9(1):12838
pubmed: 31492894
Breast Cancer Res Treat. 2011 Jul;128(2):337-46
pubmed: 20714802
Cell Mol Life Sci. 2020 Jan 23;:
pubmed: 31974656
Cell Host Microbe. 2013 Aug 14;14(2):207-15
pubmed: 23954159
J Invest Dermatol. 2011 Oct;131(10):2026-32
pubmed: 21697884
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Cancers (Basel). 2019 Apr 17;11(4):
pubmed: 30999697
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1382-7
pubmed: 23614695
Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):539-548
pubmed: 31915144
Cell Rep. 2018 Sep 25;24(13):3528-3538
pubmed: 30257213
Lancet Respir Med. 2014 Jul;2(7):548-56
pubmed: 24767767
Cancer Res. 2014 Mar 1;74(5):1311-8
pubmed: 24385213
Front Oncol. 2018 Nov 20;8:520
pubmed: 30524957
N Engl J Med. 2011 Feb 24;364(8):701-9
pubmed: 21345099
J Allergy Clin Immunol. 2017 Jul;140(1):63-75
pubmed: 27838347
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760
Cancers (Basel). 2018 Jun 22;10(7):
pubmed: 29932159
Am J Cancer Res. 2018 Sep 01;8(9):1775-1787
pubmed: 30323970
Am J Cancer Res. 2015 Sep 15;5(10):3111-22
pubmed: 26693063
J Clin Microbiol. 2012 Nov;50(11):3562-8
pubmed: 22915614
Thorax. 2020 Apr;75(4):338-344
pubmed: 31996401
PLoS One. 2014 Jun 23;9(6):e100645
pubmed: 24955983
PLoS One. 2012;7(4):e35157
pubmed: 22509397
J Med Microbiol. 2009 Nov;58(Pt 11):1401-1418
pubmed: 19556372
Genome Biol. 2016 Jul 28;17(1):163
pubmed: 27468850
Cancers (Basel). 2018 Jul 04;10(7):
pubmed: 29973551
PLoS One. 2016 Jul 18;11(7):e0159066
pubmed: 27428540
Immunity. 2015 Feb 17;42(2):344-355
pubmed: 25680274
Eur J Cancer. 2017 Nov;86:349-357
pubmed: 29078173
J Immunol Res. 2019 Jul 29;2019:1394191
pubmed: 31485458
Eur Respir Rev. 2019 Jul 8;28(152):
pubmed: 31285290
Pediatr Pulmonol. 2019 Dec;54(12):1948-1956
pubmed: 31496123

Auteurs

Taichiro Goto (T)

Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Kofu, Yamanashi 4008506, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH